Sample Page

See also

References

  1. Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 1578–. ISBN 978-0-412-46630-4.
  2. 1 2 Prasad JP (2010). “Central Nervous System”. Conceptual Pharmacology. Universities Press. pp. 236–. ISBN 978-81-7371-679-9.
  3. 1 2 Saxena AK, Saxena M (1995). “Developments in anticonvulsants”. In deStevens G, Zingel V, Leschke C, Hoeprich P, Schultz R, Mehrotra P, et al. (eds.). Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Vol. 44. Basel: Birkhäuser. pp. 185–291. doi:10.1007/978-3-0348-7161-7_6. ISBN 978-3-0348-7161-7. PMID 7644666. {{cite book}}: |journal= ignored (help)
  4. Kadam SS, Mahadik KR, Bothara KG (1 July 2007). “Central Nervous System Depresants”. Principles of Medicinal Chemistry. Vol. II. Pragati Books Pvt. Ltd. pp. 147–. ISBN 978-81-85790-03-9.

Further reading

Tandem pore domain potassium channel</span>”}]]}’>K2PsTooltip Tandem pore domain potassium channel
Sodium
Solnatide
A-317567
  • Amiloride
  • Aspirin
  • Ibuprofen
  • PcTX1
  • Chloride
    Others